Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William V Williams, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Chula Vista, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Mission Viejo, California, United States
- Facility name not stated
Orange, California, United States
- Facility name not stated
Paramount, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Santa Ana, California, United States
- Facility name not stated
Tustin, California, United States
- Facility name not stated
Colorado Springs, Colorado, United States
- Facility name not stated
St. Petersburg, Florida, United States
- Facility name not stated
Shawnee Mission, Kansas, United States
- Facility name not stated
Shreveport, Louisiana, United States
- Facility name not stated
Dearborn, Michigan, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Elizabeth, New Jersey, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
East Providence, Rhode Island, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 28 Feb 2009
- Completion
- 30 Jun 2009
- Last update posted
- 30 Oct 2012
- Registered enrollment
- 48
- Registry id
- NCT00698789
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.